Aripiprazole in autism spectrum disorders and fragile X syndrome.
Aripiprazole in autism spectrum disorders and fragile X syndrome.
复制标题
DOI:
10.1016/j.nurt.2010.04.001
复制
发表时间:
2010-07
期刊:
影响因子:
--
通讯作者:
McDougle CJ
中科院分区:
文献类型:
--
作者:
Erickson CA;Stigler KA;Posey DJ;McDougle CJ
Autism spectrum disorders (ASDs) are childhood onset developmental disorders characterized by social skills impairment, repetitive behavior, and for classic autistic disorder, a significant communication impairment. In addition to these core symptom domains, persons with ASDs frequently exhibit interfering behavioral symptoms, including irritability marked by aggression, self-injurious behavior (SIB), and severe tantrums. Aripiprazole is an atypical or newer generation antipsychotic with a unique mechanism of action impacting dopaminergic and serotonergic neurotransmission. The drug has been found efficacious for several indications, including most recently for use targeting irritability associated with autistic disorder in youth. Fragile X Syndrome (FXS) is the most common inherited cause of developmental disability and most common known single gene cause of ASDs. As in idiopathic ASDs, irritable behavior is often exhibited by persons with FXS. Research to date in this disorder, however, has not focused on this target symptom cluster. Initial pilot study has begun to assess the impact of aripiprazole on irritability in youth with FXS.
登录
查看更多内容
影响因子:
6
作者:
Masi, Gabriele;Cosenza, Angela;Salvadori, Francesco
通讯作者:
Salvadori, Francesco
DOI:
10.1002/ajmg.b.30241
发表时间:
2005-11-05
影响因子:
2.8
作者:
Hessl, D;Tassone, F;Hagerman, RJ
通讯作者:
Hagerman, RJ
影响因子:
5
作者:
Jordan, S;Koprivica, V;Altar, CA
通讯作者:
Altar, CA
影响因子:
3.4
作者:
Casey, DE;Carson, WH;Ingenito, GG
通讯作者:
Ingenito, GG
影响因子:
1.1
作者:
Erickson, Craig A.;Posey, David J.;McDougle, ChristopherJ.
通讯作者:
McDougle, ChristopherJ.